- Correction
- Open Access
- Published:
Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers*
BMC Pharmacology and Toxicology volume 20, Article number: 14 (2019)
Correction to: BMC Pharmacol Toxicol (2019) 20:5
https://doi.org/10.1186/s40360-018-0280-8
Following publication of the original article [1], the author reported their given name have been erroneously tagged as their family names.
The correct list is:
Given name Nahum Family name Méndez-Sánchez, Given name Miguel Family name Dibildox-Martinez, Given name Jahir Family name Sosa-Noguera Jahir, Given name Ramón Family name Sánchez-Medal, Given name Francisco J. Family name Flores-Murrieta.
It has been corrected in the original article as well.
The publisher apologizes for any inconvenience caused by this error.
Reference
Méndez-Sánchez N, Dibildox-Martinez M, Sosa-Noguera J, Sánchez-Medal R, et al. Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers*. BMC Pharmacol Toxicol. 2019;20:5. https://doi.org/10.1186/s40360-018-0280-8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Méndez-Sánchez, N., Dibildox-Martinez, M., Sosa-Noguera, J. et al. Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers*. BMC Pharmacol Toxicol 20, 14 (2019). https://doi.org/10.1186/s40360-019-0290-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s40360-019-0290-1